表紙:アジア太平洋の非経口栄養市場:栄養素別、国別、成長性、COVID-19の影響分析と予測(2021年~2027年)
市場調査レポート
商品コード
1029716

アジア太平洋の非経口栄養市場:栄養素別、国別、成長性、COVID-19の影響分析と予測(2021年~2027年)

Asia Pacific Parenteral Nutrition Market By Nutrient Type, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

出版日: | 発行: KBV Research | ページ情報: 英文 64 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
アジア太平洋の非経口栄養市場:栄養素別、国別、成長性、COVID-19の影響分析と予測(2021年~2027年)
出版日: 2021年08月31日
発行: KBV Research
ページ情報: 英文 64 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の非経口栄養の市場規模は、予想期間中に9.3%のCAGRで成長すると予想されています。

非経口栄養剤やアミノ酸を豊富に含む製品の消費は、肝不全、タンパク質・エネルギー栄養失調、腎不全などの症例の増加が要因となり、促進されています。さらに、間接熱量測定法の使用や脂質乳剤の活用など、非経口栄養の実質的な強化が、今後数年間の非経口栄養市場の成長を後押しすると予想されます。さらに、各国の政府機関や民間企業がヘルスケア産業の成長のために多額の支出を行っていることや、ヘルスケア産業による非経口栄養製品の採用率が高まっていることなども、非経口栄養市場の成長の要因となっています。

アジア太平洋の低開発国や発展途上国の多くの人々にとって、栄養不良は炎症性腸疾患(IBD)の最も一般的な原因の一つとなっています。この地域の多くの国が新型コロナウイルス感染症のパンデミックの発生で大きな打撃を受けたため、非経口栄養剤は世界中の患者の新型コロナウイルス感染症に伴う栄養不良の治療に重要な役割を果たしました。

さらに、癌、クローン病、HIVなどの慢性疾患が増加していることも、予想期間中の地域の非経口栄養市場の成長を促進すると予想されます。さらに、多数の未熟児が非経口栄養剤で栄養を摂取しています。静脈注射は、医師や看護師が患者に水分補給をしたり、血液量の減少を補ったり、薬剤を投与したりするために、多くの国の医療システムにおいて重要な役割を果たしています。これらの要因により、アジア太平洋では非経口栄養の需要が高まっています。

当レポートでは、アジア太平洋地域の非経口栄養市場を調査し、市場概要、市場の成長要因、競合情勢や主要企業のプロファイル、栄養素別・国別の市場分析などの情報を提供しています。

目次

第1章 市場の範囲と調査手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主要因

第3章 アジア太平洋地域の非経口栄養市場:栄養素別

  • 単回投与アミノ酸溶液
  • 非経口脂質エマルジョン
  • 炭水化物
  • 微量元素
  • ビタミン・ミネラル

第4章 アジア太平洋地域の非経口栄養市場:国別

  • 中国
  • 日本
  • インド
  • 韓国
  • シンガポール
  • マレーシア
  • その他

第5章 企業プロファイル

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited
図表

LIST OF TABLES

  • TABLE 1 Asia Pacific Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 2 Asia Pacific Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 3 Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 4 Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 5 Asia Pacific Single Dose Amino Acid Solution Market by Country, 2017 - 2020, USD Million
  • TABLE 6 Asia Pacific Single Dose Amino Acid Solution Market by Country, 2021 - 2027, USD Million
  • TABLE 7 Asia Pacific Parenteral Lipid Emulsion Market by Country, 2017 - 2020, USD Million
  • TABLE 8 Asia Pacific Parenteral Lipid Emulsion Market by Country, 2021 - 2027, USD Million
  • TABLE 9 Asia Pacific Carbohydrates Market by Country, 2017 - 2020, USD Million
  • TABLE 10 Asia Pacific Carbohydrates Market by Country, 2021 - 2027, USD Million
  • TABLE 11 Asia Pacific Trace Elements Market by Country, 2017 - 2020, USD Million
  • TABLE 12 Asia Pacific Trace Elements Market by Country, 2021 - 2027, USD Million
  • TABLE 13 Asia Pacific Other Nutrient Type Market by Country, 2017 - 2020, USD Million
  • TABLE 14 Asia Pacific Other Nutrient Type Market by Country, 2021 - 2027, USD Million
  • TABLE 15 Asia Pacific Parenteral Nutrition Market by Country, 2017 - 2020, USD Million
  • TABLE 16 Asia Pacific Parenteral Nutrition Market by Country, 2021 - 2027, USD Million
  • TABLE 17 China Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 18 China Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 19 China Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 20 China Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 21 Japan Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 22 Japan Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 23 Japan Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 24 Japan Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 25 India Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 26 India Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 27 India Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 28 India Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 29 South Korea Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 30 South Korea Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 31 South Korea Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 32 South Korea Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 33 Singapore Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 34 Singapore Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 35 Singapore Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 36 Singapore Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 37 Malaysia Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 38 Malaysia Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 39 Malaysia Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 40 Malaysia Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 41 Rest of Asia Pacific Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 42 Rest of Asia Pacific Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 43 Rest of Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 44 Rest of Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 45 Key Information - Vifor Pharma Management Ltd.
  • TABLE 46 Key Information - Baxter International, Inc.
  • TABLE 47 Key Information - Allergan PLC
  • TABLE 48 key Information - B. Braun Melsungen AG
  • TABLE 49 key information - Fresenius SE & Co. KGaA
  • TABLE 50 key information - Grifols S.A.
  • TABLE 51 Key Information - Pfizer, Inc.
  • TABLE 52 key information - ICU Medical, Inc.
  • TABLE 53 Key Information - Anhui Medipharm Co., Ltd.
  • TABLE 54 Key Information - ACULIFE HEALTHCARE PRIVATE LIMITED

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Baxter International, Inc.
目次

The Asia Pacific Parenteral Nutrition Market would witness market growth of 9.3% CAGR during the forecast period (2021-2027).

The consumption of parenteral and amino acid-rich products is driven by the growing cases of hepatic insufficiency, protein-energy malnutrition, and renal insufficiency. Moreover, the substantial enhancements in parenteral nutrition like usage of indirect calorimetry and lipid emulsions optimizations are expected to boost the growth of the parenteral nutrition market in the next few years. Furthermore, some of the factors such as huge spending on the overall growth of the healthcare industry by the government bodies and private enterprises of various nations and increase in the adoption rate of parenteral nutrition products by the healthcare industry are responsible for the growth of the parenteral nutrition market.

Malnutrition is one the most common cause of inflammatory bowel disease (IBD) among a large population in both under-developed and developing countries of this region. As many of the countries of the region were hit hard by the outbreak of the COVID-19 pandemic, parenteral nutrition played a pivotal role in the treatment of the COVID-19 infection-associated malnutrition in patients across the world.

Moreover, the increase in the occurrence of chronic disorders like cancer, Crohn's disease, HIV, and others are expected to fuel the growth of the regional parenteral nutrition market during the forecasting period. Furthermore, numerous premature babies get nutrition via parenteral nutrition. Intravenous solutions have been a crucial component of the healthcare system of many countries, allowing doctors & nurses to provide hydration to their patients, substitute loss of blood volume, and administer drugs. Therefore, these factors are set to boost the demand for parenteral nutrition in the regional market.

The China market dominated the Asia Pacific Parenteral Lipid Emulsion Market by Country in 2020, thereby, achieving a market value of $205.1 million by 2027. The Japan market is exhibiting a CAGR of 9.5% during (2021 - 2027). Additionally, The India market is poised to grow at a CAGR of 9.5% during (2021 - 2027).

Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.

Scope of the Study

Market Segments covered in the Report:

By Nutrient Type

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements,
  • Vitamins & Minerals

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Parenteral Nutrition Market, by Nutrient Type
    • 1.4.2 Asia Pacific Parenteral Nutrition Market, by Asia Pacific
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 COVID-19 Impact
      • 2.1.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Asia Pacific Parenteral Nutrition Market by Nutrient Type

  • 3.1 Asia Pacific Single Dose Amino Acid Solution Market by Country
  • 3.2 Asia Pacific Parenteral Lipid Emulsion Market by Country
  • 3.3 Asia Pacific Carbohydrates Market by Country
  • 3.4 Asia Pacific Trace Elements Market by Country
  • 3.5 Asia Pacific Other Nutrient Type Market by Country

Chapter 4. Asia Pacific Parenteral Nutrition Market by Country

  • 4.1 China Parenteral Nutrition Market
    • 4.1.1 China Parenteral Nutrition Market by Nutrient Type
  • 4.2 Japan Parenteral Nutrition Market
    • 4.2.1 Japan Parenteral Nutrition Market by Nutrient Type
  • 4.3 India Parenteral Nutrition Market
    • 4.3.1 India Parenteral Nutrition Market by Nutrient Type
  • 4.4 South Korea Parenteral Nutrition Market
    • 4.4.1 South Korea Parenteral Nutrition Market by Nutrient Type
  • 4.5 Singapore Parenteral Nutrition Market
    • 4.5.1 Singapore Parenteral Nutrition Market by Nutrient Type
  • 4.6 Malaysia Parenteral Nutrition Market
    • 4.6.1 Malaysia Parenteral Nutrition Market by Nutrient Type
  • 4.7 Rest of Asia Pacific Parenteral Nutrition Market
    • 4.7.1 Rest of Asia Pacific Parenteral Nutrition Market by Nutrient Type

Chapter 5. Company Profiles

  • 5.1 Vifor Pharma Management Ltd.
    • 5.1.1 Company Overview
    • 5.1.2 Financial Analysis
    • 5.1.3 Research & Development Expenses
  • 5.2 Baxter International, Inc.
    • 5.2.1 Company Overview
    • 5.2.2 Financial Analysis
    • 5.2.3 Regional Analysis
    • 5.2.4 Research & Development Expense
    • 5.2.1 Recent strategies and developments:
      • 5.2.1.1 Partnerships, Collaborations, and Agreements:
      • 5.2.1.2 Product Launches and Product Expansions:
      • 5.2.1.3 Approvals and Trails:
  • 5.3 Allergan PLC (AbbVie)
    • 5.3.1 Company Overview
    • 5.3.2 Financial Analysis
    • 5.3.3 Regional Analysis
    • 5.3.4 Research & Development Expense
  • 5.4 B. Braun Melsungen AG
    • 5.4.1 Company Overview
    • 5.4.2 Financial Analysis
    • 5.4.3 Segmental and Regional Analysis
    • 5.4.4 Research & Development Expenses
  • 5.5 Fresenius SE & Co. KGaA
    • 5.5.1 Company Overview
    • 5.5.2 Financial Analysis
    • 5.5.3 Segmental and Regional Analysis
    • 5.5.4 Research & Development Expenses
  • 5.6 Grifols S.A.
    • 5.6.1 Company Overview
    • 5.6.2 Financial Analysis
    • 5.6.3 Segmental and Regional Analysis
    • 5.6.4 Research & Development Expense
  • 5.7 Pfizer, Inc.
    • 5.7.1 Company Overview
    • 5.7.2 Financial Analysis
    • 5.7.3 Regional Analysis
    • 5.7.4 Research & Development Expenses
  • 5.8 ICU Medical, Inc.
    • 5.8.1 Company Overview
    • 5.8.2 Recent strategies and developments:
      • 5.8.2.1 Partnerships, Collaborations, and Agreements:
  • 5.9 Anhui Medipharm Co., Ltd.
    • 5.9.1 Company Overview
  • 5.10. Aculife Healthcare Private Limited
    • 5.10.1 Company Overview